Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC25A37 |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → SLC25A37 |
| (<<) BCL2L1 → SLC25A37 |
| (<<) IRAK1 → SLC25A37 |
| (<<) KCNN4 → SLC25A37 |
| (<<) PLCB3 → SLC25A37 |
| (<<) PPP1CA → SLC25A37 |
| (<<) PRR7 → SLC25A37 |
| (<<) RDX → SLC25A37 |
| (<<) RPL35 → SLC25A37 |
| (<<) RPL36 → SLC25A37 |
| (<<) SF3A2 → SLC25A37 |
| (<<) SFN → SLC25A37 |
| (<<) SLC5A1 → SLC25A37 |
| (<<) STX1A → SLC25A37 |
| (<<) TAF9 → SLC25A37 |
| (<<) TK1 → SLC25A37 |
| Downstream (Children) |
|---|
| SLC25A37 → BCAM (>>) |
| SLC25A37 → CTRB2 (>>) |
| SLC25A37 → FOSL1 (>>) |
| SLC25A37 → FZD9 (>>) |
| SLC25A37 → GNG5 (>>) |
| SLC25A37 → JAK3 (>>) |
| SLC25A37 → KRT16 (>>) |
| SLC25A37 → NFATC4 (>>) |
| SLC25A37 → NOTCH4 (>>) |
| SLC25A37 → POU3F3 (>>) |
| SLC25A37 → RCAN1 (>>) |
| SLC25A37 → SGCA (>>) |
| SLC25A37 → TPM2 (>>) |
